Fast Five Quiz: Can You Answer These Challenging Cardiology Questions?

Ali A. Sovari, MD; Yasmine S. Ali, MD; Shabir Bhimji, MD, PhD; Wai Hong Wilson Tang, MD


March 13, 2017

In general, sympathomimetic drugs should be avoided because they increase the extent of myocardial necrosis and mortality. Beta-blockers should be avoided in the acutely decompensating phase of illness. Treatment of myocarditis includes supportive therapy for symptoms of acute heart failure with use of diuretics, nitroglycerin/nitroprusside, and angiotensin-converting enzyme (ACE) inhibitors. Inotropic drugs (eg, dobutamine, milrinone) may be necessary for severe decompensation, although they are highly arrhythmogenic. Long-term treatment follows the same medical regimen, including ACE inhibitors, beta-blockers, and aldosterone receptor antagonists. However, in some instances, some of these drugs cannot be implemented initially because of hemodynamic instability.

For more information on the management of myocarditis, read here.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.